The diagnosis of genital herpes is mainly based on clinical manifestations, and laboratory diagnosis is not the main one. However, when the clinical diagnosis cannot be confirmed or needs to be differentiated from other genital ulcers, laboratory tests can help with clinical diagnosis. In addition, laboratory diagnosis is recommended to determine whether full-term pregnant women and newborns are infected with HSV, and is also used in epidemiological surveys. Virus isolation and culture plus PCR is the "gold standard" for laboratory detection of HSV. The improved culture method can shorten the time for virus detection, and this method is used first for symptomatic patients in clinical practice.
The preferred treatment for genital herpes is drug treatment. Internal drug treatment is divided into the following categories:
1. Antiviral drugs
(1) Initial onset (optional for primary genital herpes)
① Acyclovir, 0.2g, 4-5 times/day, orally, for 7-10 days.
②Valacyclovir, 0.3g, twice a day, orally, for 7 to 10 days.
(2) Recurrent genital herpes can be treated with
① Short course of treatment: acyclovir, 0.2g, 4-5 times/day, for 5-7 days; or valacyclovir, 0.3g, 2 times/day, for 5-7 days.
② Long course of treatment: acyclovir, 0.2g, 4-5 times/day, for more than 4 consecutive months; or valacyclovir, 0.3g, 1-2 times/day, for more than 4 consecutive months.
2. Interferon is suitable for recurrent genital herpes. Interferon-a or interferon-ß can be selected, and the course of treatment is several months.
3. Levadazole is suitable for recurrent genital herpes. The dosage is 50 mg, 3 times a day, for 3 consecutive days and 11 days off, for a total of more than 4 months
